Reductions in kinesin expression are associated with nitric oxide-induced axonal damage

Journal of Neuroscience Research

Volumn 93, Issue 6, 2015, Pages 882-892

  Redondo, Juliana ^a   Hares, Kelly ^a   Wilkins, Alastair ^a   Scolding, Neil ^a   Kemp, Kevin ^a  

^a UNIVERSITY OF BRISTOL   (United Kingdom)

Author keywords

Axonal transport; Mesenchymal stem cells; Motor proteins; Neuroprotection; Nitrosative stress

Indexed keywords

KINESIN; NITRIC OXIDE; LEUKOCYTE ANTIGEN; NEUROFILAMENT PROTEIN; NEUROFILAMENT PROTEIN H; SCAVENGER;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; AXONAL INJURY; BRAIN CELL; CONTROLLED STUDY; EMBRYO; GENE; GENE EXPRESSION; IMMUNOCYTOCHEMISTRY; IN VITRO STUDY; KIF21B GENE; KIF5A GENE; MESENCHYMAL STEM CELL; NERVE CELL CULTURE; NERVE FIBER TRANSPORT; NEUROFILAMENT; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEPLETION; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; RAT; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; ANALYSIS OF VARIANCE; ANIMAL; AXON; BONE MARROW CELL; BRAIN CORTEX; CELL CULTURE; CELL SURVIVAL; COCULTURE; CYTOLOGY; DRUG EFFECTS; GENE EXPRESSION REGULATION; GENETICS; HUMAN; MAMMALIAN EMBRYO; METABOLISM; NERVE CELL; PATHOLOGY; TIME FACTOR;

ANALYSIS OF VARIANCE; ANIMALS; ANTIGENS, CD; AXONS; BONE MARROW CELLS; CELL SURVIVAL; CELLS, CULTURED; CEREBRAL CORTEX; COCULTURE TECHNIQUES; EMBRYO, MAMMALIAN; FREE RADICAL SCAVENGERS; GENE EXPRESSION REGULATION; HUMANS; KINESIN; NEUROFILAMENT PROTEINS; NEURONS; NITRIC OXIDE; RATS; TIME FACTORS;

EID: 84927555612     PISSN: 03604012     EISSN: 10974547     Source Type: Journal    
DOI: 10.1002/jnr.23556     Document Type: Article

References (33)

1. Brown GC, Bal-Price A. 2003. Inflammatory neurodegeneration mediated by nitric oxide, glutamate, and mitochondria. Mol Neurobiol 27:325-355.
2. Chen J, Li Y, Katakowski M, Chen X, Wang L, Lu D, Lu M, Gautam SC, Chopp M. 2003. Intravenous bone marrow stromal cell therapy reduces apoptosis and promotes endogenous cell proliferation after stroke in female rat. J Neurosci Res 73:778-786.
3. Chu Y, Morfini GA, Langhamer LB, He Y, Brady ST, Kordower JH. 2012. Alterations in axonal transport motor proteins in sporadic and experimental Parkinson's disease. Brain 135:2058-2073.
4. Coleman M. 2005. Axon degeneration mechanisms: commonality amid diversity. Nat Rev Neurosci 6:889-898.
5. Crigler L, Robey RC, Asawachaicharn A, Gaupp D, Phinney DG. 2006. Human mesenchymal stem cell subpopulations express a variety of neuroregulatory molecules and promote neuronal cell survival and neuritogenesis. Exp Neurol 198:54-64.
6. Goris A, Boonen S, D'Hooghe M B, Dubois B. 2010. Replication of KIF21B as a susceptibility locus for multiple sclerosis. J Med Genet 47:775-776.
7. Hares K, Kemp K, Rice C, Gray E, Scolding N, Wilkins A. 2013. Reduced axonal motor protein expression in nonlesional grey matter in multiple sclerosis. Mult Scler (Epub ahead of print).
8. Hirokawa N, Noda Y, Tanaka Y, Niwa S. 2009. Kinesin superfamily motor proteins and intracellular transport. Nat Rev Mol Cell Biol 10:682-696.
9. Kemp K, Hares K, Mallam E, Heesom KJ, Scolding N, Wilkins A. 2010. Mesenchymal stem cell-secreted superoxide dismutase promotes cerebellar neuronal survival. J Neurochem 114:1569-1580.
10. Kemp K, Mallam E, Hares K, Witherick J, Scolding N, Wilkins A. 2011. Mesenchymal stem cells restore frataxin expression and increase hydrogen peroxide scavenging enzymes in Friedreich ataxia fibroblasts. PloS One 6:e26098.
11. Knott AB, Bossy-Wetzel E. 2009. Nitric oxide in health and disease of the nervous system. Antioxid Redox Signal 11:541-554.
12. Kreutzer M, Seehusen F, Kreutzer R, Pringproa K, Kummerfeld M, Claus P, Deschl U, Kalkul A, Beineke A, Baumgartner W, Ulrich R. 2012. Axonopathy is associated with complex axonal transport defects in a model of multiple sclerosis. Brain Pathol 22:454-471.
13. Lanza C, Morando S, Voci A, Canesi L, Principato MC, Serpero LD, Mancardi G, Uccelli A, Vergani L. 2009. Neuroprotective mesenchymal stem cells are endowed with a potent antioxidant effect in vivo. J Neurochem 110:1674-1684.
14. Marszalek JR, Weiner JA, Farlow SJ, Chun J, Goldstein LS. 1999. Novel dendritic kinesin sorting identified by different process targeting of two related kinesins: KIF21A and KIF21B. J Cell Biol 145:469-479.
15. Medana IM, Esiri MM. 2003. Axonal damage: a key predictor of outcome in human CNS diseases. Brain 126:515-530.
16. Morfini G, Szebenyi G, Elluru R, Ratner N, Brady ST. 2002. Glycogen synthase kinase 3 phosphorylates kinesin light chains and negatively regulates kinesin-based motility. EMBO J 21:281-293.
17. Musumeci O, Bassi MT, Mazzeo A, Grandis M, Crimella C, Martinuzzi A, Toscano A. 2011. A novel mutation in KIF5A gene causing hereditary spastic paraplegia with axonal neuropathy. Neurol Sci 32:665-668.
18. Nixon RA, Shea TB. 1992. Dynamics of neuronal intermediate filaments: a developmental perspective. Cell Motil Cytoskel 22:81-91.
19. Pant HC. 1988. Dephosphorylation of neurofilament proteins enhances their susceptibility to degradation by calpain. Biochem J 256:665-668.
20. Perrot R, Berges R, Bocquet A, Eyer J. 2008. Review of the multiple aspects of neurofilament functions, and their possible contribution to neurodegeneration. Mol Neurobiol 38:27-65.
21. Reid E, Kloos M, Ashley-Koch A, Hughes L, Bevan S, Svenson IK, Graham FL, Gaskell PC, Dearlove A, Pericak-Vance MA, Rubinsztein DC, Marchuk DA. 2002. A kinesin heavy chain (KIF5A) mutation in hereditary spastic paraplegia (SPG10). Am J Hum Genet 71:1189-1194.
22. Sato-Yoshitake R, Yorifuji H, Inagaki M, Hirokawa N. 1992. The phosphorylation of kinesin regulates its binding to synaptic vesicles. J Biol Chem 267:23930-23936.
23. Smith KJ, Lassmann H. 2002. The role of nitric oxide in multiple sclerosis. Lancet Neurol 1:232-241.
24. Stokin GB, Lillo C, Falzone TL, Brusch RG, Rockenstein E, Mount SL, Raman R, Davies P, Masliah E, Williams DS, Goldstein LS. 2005. Axonopathy and transport deficits early in the pathogenesis of Alzheimer's disease. Science 307:1282-1288.
25. Uccelli A, Laroni A, Freedman MS. 2011. Mesenchymal stem cells for the treatment of multiple sclerosis and other neurological diseases. Lancet Neurol 10:649-656.
26. Walsh GS, Krol KM, Crutcher KA, Kawaja MD. 1999. Enhanced neurotrophin-induced axon growth in myelinated portions of the CNS in mice lacking the p75 neurotrophin receptor. J Neurosci 19:4155-4168.
27. Whone AL, Kemp K, Sun M, Wilkins A, Scolding NJ. 2012. Human bone marrow mesenchymal stem cells protect catecholaminergic and serotonergic neuronal perikarya and transporter function from oxidative stress by the secretion of glial-derived neurotrophic factor. Brain Res 1431:86-96.
28. Wilkins A, Chandran S, Compston A. 2001. A role for oligodendrocyte-derived IGF-1 in trophic support of cortical neurons. Glia 36:48-57.
29. Wilkins A, Kemp K, Ginty M, Hares K, Mallam E, Scolding N. 2009. Human bone marrow-derived mesenchymal stem cells secrete brain-derived neurotrophic factor, which promotes neuronal survival in vitro. Stem Cell Res 3:63-70.
30. Xia CH, Roberts EA, Her LS, Liu X, Williams DS, Cleveland DW, Goldstein LS. 2003. Abnormal neurofilament transport caused by targeted disruption of neuronal kinesin heavy chain KIF5A. J Cell Biol 161:55-66.
31. Yabe JT, Jung C, Chan WK, Shea TB. 2000. Phospho-dependent association of neurofilament proteins with kinesin in situ. Cell Motil Cytoskel 45:249-262.
32. Yuan H, Gerencser AA, Liot G, Lipton SA, Ellisman M, Perkins GA, Bossy-Wetzel E. 2007. Mitochondrial fission is an upstream and required event for bax foci formation in response to nitric oxide in cortical neurons. Cell Death Differ 14:462-471.
33. Zhang J, Li Y, Chen J, Cui Y, Lu M, Elias SB, Mitchell JB, Hammill L, Vanguri P, Chopp M. 2005. Human bone marrow stromal cell treatment improves neurological functional recovery in EAE mice. Exp Neurol 195:16-26.